BioRem Inc.
BIRMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $48,289 | $15,645 | $13,630 | $28,562 |
| - Cash | $5,213 | $2,292 | $3,775 | $4,471 |
| + Debt | $3,557 | $4,185 | $4,746 | $5,666 |
| Enterprise Value | $46,633 | $17,538 | $14,601 | $29,756 |
| Revenue | $37,419 | $25,165 | $28,863 | $24,478 |
| % Growth | 48.7% | -12.8% | 17.9% | – |
| Gross Profit | $10,056 | $7,022 | $8,762 | $6,236 |
| % Margin | 26.9% | 27.9% | 30.4% | 25.5% |
| EBITDA | $4,817 | $3,445 | $2,991 | $2,677 |
| % Margin | 12.9% | 13.7% | 10.4% | 10.9% |
| Net Income | $3,044 | $2,179 | $1,613 | $1,297 |
| % Margin | 8.1% | 8.7% | 5.6% | 5.3% |
| EPS Diluted | 0.16 | 0.13 | 0.092 | 0.035 |
| % Growth | 23.1% | 41.5% | 164.8% | – |
| Operating Cash Flow | $3,685 | $490 | $1,445 | $3,782 |
| Capital Expenditures | -$372 | -$553 | -$203 | -$76 |
| Free Cash Flow | $3,313 | -$63 | $1,242 | $3,706 |